European Congress of Biotechnology

ECB serves as a forum for exchange of cutting-edge research, practical solutions, and cross-sector collaboration aimed at advancing biotechnology at the European and global scale.

Who the audience is and how many attend

Audience

• Academic and industrial biotechnology researchers
• Bioprocessing and industrial biotech leaders
• Entrepreneurs and startup founders in biotech and bioeconomy sectors
• Policy, regulatory and public-sector stakeholders in science and innovation
• Representatives from pharma, medtech, agbio and enabling technology firms
• Educators and students engaged in biotechnology disciplines

Scale

• Attendees: ~2,000+ (typical for ECB congress editions)
• A multidisciplinary scientific programme featuring parallel sessions, poster presentations, plenary talks, and special interest tracks

What to expect

• Multi-day scientific and industry programme spanning biotechnology research, industrial applications and translating science into practice
• Parallel sessions covering emerging areas (e.g., synthetic biology, bioeconomy, bioprocessing, data/AI in biotech)
• Poster and dialogue-driven formats fostering exchange between academia, industry and policy audiences
• Expo and sponsor participation alongside the scientific programme
• Networking opportunities across sectors and career stages in one of Europe’s major cities, Kraków, for science and innovation collaboration